Clinical Research Directory
Browse clinical research sites, groups, and studies.
GREENWATER 2.0: Reducing Iodinated Contrast Agents in Hospital Wastewater
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Summary
The goal of this observational study is to learn if using a dedicated urine collection device after CT scans can help reduce the amount of iodinated contrast agent released into hospital wastewater in adult outpatients undergoing contrast-enhanced CT scans. The main questions it aims to answer are: * Does the dedicated urine collection device improve patient acceptance and compliance with post-contrast urine collection? * How much iodinated contrast agent can be recovered from urine collected after CT scans? Participants will: * Have their planned CT scan with iodinated contrast agent as part of their regular medical care. * Wait in the radiology department for about 60 minutes after the contrast injection. * Use a dedicated urine collection device before leaving the hospital. * Answer short questions about their experience with the device. This does not change the CT scan, the contrast agent used, or the standard clinical imaging procedure. The only additional procedure is the use of the dedicated urine collection device after the scan.
Official title: GREENWATER 2.0: Cutting Edge Solution for Reducing Iodinated Contrast Agents Via Post-Administration Collection Device
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
416
Start Date
2026-03-10
Completion Date
2026-12
Last Updated
2026-06-24
Healthy Volunteers
No
Interventions
Dedicated Urine Collection Device (Toilet)
A dedicated urine collection device installed in the radiology department for use after contrast-enhanced CT scans. Participants will undergo their CT scan according to standard clinical practice, with no change to the imaging protocol, contrast agent selection, or contrast administration. After iodinated contrast injection, participants will be asked to wait approximately 60 minutes and then use the dedicated device before leaving the hospital. The collected urine will be used to assess the potential recovery of iodinated contrast agent residues and the feasibility of this workflow in routine radiology practice.
Locations (1)
IRCCS Ospedale Galeazzi - Sant'Ambrogio
Milan, MI, Italy